WebJun 15, 2016 · Glassia is available as a single-use vial containing approximately 1g of functional alpha-1 proteinase inhibitor in 50mL solution for injection. It is preservative- … WebOct 31, 2024 · Applies to alpha 1-proteinase inhibitor: intravenous powder for injection, intravenous solution. Respiratory Common (1% to 10%): Cough, dyspnea, rhinorrhea, pharyngitis Uncommon (0.1% to 1%): Cough increased Frequency not reported: COPD exacerbations [ Ref] Nervous system Common (1% to 10%): Headache, dizziness [ Ref] …
Injection, alpha 1 proteinase inhibitor (human), (GLASSIA), …
WebJ0178 Aflibercept injection (ophthalmic) J0180 Agalsidase beta injection J0207 Amifostine J0220 Alglucosidase alfa injection J0221 Lumizyme injection J0256 Alpha 1 proteinase inhibitor J0257 Glassia injection J0285 Amphotericin B J0287 Amphotericin b lipid complex J0289 Amphotericin b liposome inj J0348 Anidulafungin injection WebMar 13, 2024 · What Is Glassia? Glassia [Alpha1-Proteinase Inhibitor (Human)] Injection Solution is an Alpha1-Proteinase Inhibitor (Human) (Alpha1-PI) indicated for chronic augmentation and maintenance therapy in adults with clinically evident emphysema due to severe hereditary deficiency of Alpha1-PI (alpha-antitrypsin deficiency). Glassia … pro small form factor 400 g9
Alpha1-Proteinase Inhibitors BCBSND
WebNP, Glassia, Prolastin-C, and Zemaira) medically necessary for the treatment of emphysema due to AAT deficiency when all of the following criteria are met: A. The member’s pretreatment serum AAT leve l is less than 11 microm ol/L (80 mg/dL ... Available for injection: aproximately 1 gram of functional alpha1-PI in 50 mL of ready ... WebOct 12, 2024 · Glassia is a liquid form of alpha 1-proteinase inhibitor that does not need to be mixed with a diluent. If you are using the injections at home, be sure you understand how to properly mix and store the medicine. This medication comes with patient instructions for safe and effective use. Follow these directions carefully. WebJul 1, 2024 · Reauthorization Criteria. Repeat doses of AAT inhibitor therapy with Aralast NP, Glassia, Prolastin-C or Zemaira may be considered medically necessary for individuals who meet the clinical requirements for AAT inhibitor at therapy initiation and who demonstrate a substantial reduction in the rate of deterioration of lung function as … pro slowpitch softball